Rinat Bernstein Molho

Rinat Bernstein Molho

UNVERIFIED PROFILE

Are you Rinat Bernstein Molho?   Register this Author

Register author
Rinat Bernstein Molho

Rinat Bernstein Molho

Publications by authors named "Rinat Bernstein Molho"

Are you Rinat Bernstein Molho?   Register this Author

18Publications

283Reads

37Profile Views

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer.

Fam Cancer 2019 Dec 19. Epub 2019 Dec 19.

The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-019-00157-1DOI Listing
December 2019

Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?

Breast 2019 Nov 6;49:81-86. Epub 2019 Nov 6.

The Meirav High-risk Clinic - Chaim Sheba Medical Center, Tel-Hashomer, Israel; Oncogenetics Unit, Institute of Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2019.10.012DOI Listing
November 2019

Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.

Breast Cancer Res Treat 2019 Jul 12;176(1):165-170. Epub 2019 Apr 12.

Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05228-6DOI Listing
July 2019

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.

Cancer 2019 03 29;125(5):698-703. Epub 2018 Nov 29.

Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31842DOI Listing
March 2019

The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.

Cancer Causes Control 2019 Jan 30;30(1):97-101. Epub 2018 Nov 30.

Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, 52621, Tel-Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-018-1106-0DOI Listing
January 2019

Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.

Breast 2018 Aug 22;40:141-146. Epub 2018 May 22.

Department of Oncology the Pinchas Burstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel Affiliated to Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; The Pinchas Burstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel Affiliated to Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2018.05.007DOI Listing
August 2018

Accuracy of Risk Prediction Models for Breast Cancer and Mutation Carrier Probabilities in Israel.

Anticancer Res 2018 Aug;38(8):4557-4563

Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12760DOI Listing
August 2018

Mutational analysis of candidate genes in Israeli male breast cancer cases.

Breast Cancer Res Treat 2018 Jul 21;170(2):399-404. Epub 2018 Mar 21.

The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Sheba Medical Center, Tel-Hahsomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4765-3DOI Listing
July 2018

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

Breast Cancer Res Treat 2018 02 30;167(3):697-702. Epub 2017 Oct 30.

Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center, Tel-Hashomer, 52621, Ramat Gan, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4551-7DOI Listing
February 2018

Cranial irradiation in childhood mimicking neurofibromatosis type II.

Am J Med Genet A 2017 Jun 19;173(6):1635-1639. Epub 2017 Apr 19.

The Gilbert Israeli Neurofibromatosis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38211DOI Listing
June 2017

Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas.

Cancer Chemother Pharmacol 2012 Dec 28;70(6):855-60. Epub 2012 Sep 28.

The Unit of Bone and Soft Tissue Oncology, Division of Oncology, Tel-Aviv Sourasky Medical Center, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-1968-xDOI Listing
December 2012

Metastatic uterine leiomyosarcomas: a single-institution experience.

Int J Gynecol Cancer 2010 Feb;20(2):255-60

Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181c9e289DOI Listing
February 2010

Targeting the mammalian target of rapamycin in myxoid chondrosarcoma.

Anticancer Drugs 2008 Nov;19(10):1019-21

Tel-Aviv Sourasky Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0b013e328312c0e5DOI Listing
November 2008

The complexity of management of pregnancy-associated malignant soft tissue and bone tumors.

Gynecol Obstet Invest 2008 18;65(2):89-95. Epub 2007 Sep 18.

Unit of Bone and Soft Tissue Oncology, Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000108402DOI Listing
April 2008